MLSC Early-Stage Company Programs and Resources Info Session

Join us on Wednesday, May 6th to learn how the MLSC supports early-stage life science companies through MassNextGen, Impact Catalyst, and other initiatives.

The Massachusetts Life Sciences Center (MLSC) has launched the Impact Catalyst program, a brand-new seed-stage funding program designed to accelerate innovation in underinvested and hard-to-commercialize areas in the life sciences, and is simultaneously accepting applications for the latest round of the Massachusetts Next Generation (MassNextGen) Initiative to support early-stage underrepresented entrepreneurs in the ecosystem. The application period for both programs runs from March 16 to June 12, 2026 at 1 p.m. EST.

A special thank you to our Anchor Platinum Sponsor, Takeda, and all our MassNextGen sponsors, including Johnson & Johnson Innovation, Massachusetts Biomedical Initiatives, ABI-LAB, Berkshire Innovation Center, Cambridge Scientific Labs, Hatch.Bio, InnoVenture Labs, Labshares, M2D2, Mansfield Bio-Incubator, Portal Innovations, and the UMass Boston Venture Development Center. Together, we are helping to create a diverse, inclusive, and equitable ecosystem.

ABI‑LAB enables life‑science companies with turnkey BSL‑2 lab space, shared instrumentation, and integrated support services that simplify operations and accelerate research. Free parking can be found in front of and on both sides of the building.

Please note: If we exceed 20 registrants external to ABI-Lab, the first 20 registrants will be given priority given space constraints.